ライフサイエンスコーパス: NRT

1 NRT fibers had beaded shapes and coursed in a posterior

2 NRT had no effect on prolonged abstinence from smoking b

3 NRT recipients were compared with local survey-derived d

4 s with placebo in pregnant smokers; although NRT doubled cessation rates in the first 4 weeks, by del

5 dent continued to smoke, the stop rate among NRT recipients was 20%.

6 Among those genes, AMT, NRT and AQP for N uptake and GOGAT and GS for N assimila

7 s increased 61.4% (from 38.1% to 61.5%), and NRT use among quitters increased 50.5% (from 9.3% to 14.

8 erm users of both combustible cigarettes and NRT.

9 d in the IAT group compared with the IVT and NRT groups combined: internal carotid artery terminus (7

10 The e-cigarette-only and NRT-only users had significantly lower metabolite levels

11 Natural bond order and NRT analyses of the electronic structure of the complex

12 ion of evoked IPSCs was studied in relay and NRT cells by applying pairs of 100 Hz stimulus bursts se

13 cessation advantage was only observed before NRT became widely available over-the-counter (August 199

14 equations to examine the association between NRT use (any use and <4 weeks, 4.0-7.9 weeks, 8.0-11.9 w

15 at the inhibitory GABAergic synapses between NRT and TC neurons of the rat somatosensory nucleus deve

16 Mean mIPSC amplitude was 20 pA in both NRT and relay cells at a holding potential of 0 mV.

17 presynaptic autoinhibition of IPSCs in both NRT and relay cells, and to direct activation of a small

18 smoking generally exceed those delivered by NRTs, and the cardiovascular effects of nicotine are, in

19 ncluding 1 prequit week; n = 424); and (3) C-NRT (nicotine patch + nicotine lozenge; n = 421).

20 [50/241]; varenicline, 19.1% [81/424]; and C-NRT, 20.2% [85/421]).

21 55/241]; varenicline, 23.6% [100/424]; and C-NRT, 26.8% [113/421]) or at 52 weeks (nicotine patch, 20

22 tment with nicotine patch, varenicline, or C-NRT produced no significant differences in biochemically

23 I, -10.8% to 2.8%); and for varenicline vs C-NRT, -3.3% (95% CI, -9.1% to 2.6%).

24 .76% (95% CI, -7.4% to 5.9%); for patch vs C-NRT, -4.0% (95% CI, -10.8% to 2.8%); and for varenicline

25 garette-e-cigarette or combustible cigarette-NRT users (n = 36 to 37 per group; total n = 181).

26 e-e-cigarette, or dual combustible cigarette-NRT users.

27 e cigarette-only, dual combustible cigarette-NRT, and dual combustible cigarette-e-cigarette users ha

28 Varenicline (27.6%) and combination NRT (31.5%) (eg, patch plus inhaler) were most effective

29 Since becoming available over the counter, NRT appears no longer effective in increasing long-term

30 dan), issued as two 4-week supplies (521 for NRT group, 529 for placebo group) [Corrected].

31 d SNPs that display much larger t values for NRT vs placebo comparisons.

32 Compared with abstaining from NRT when attempting to quit smoking, using NRT for less

33 itatively via resonance models produced from NRT analysis and is related to the amount of CN double b

34 have investigated the effect of gestational NRT use beyond birth.

35 ive singleton births (445 of (88%) 503 given NRT and 446 (88%) of 507 given placebo).

36 In NRT cells baclofen induced a linear postsynaptic conduct

37 an mIPSC frequencies were 0.83 and 2.2 Hz in NRT and relay cells, respectively.

38 ngleton infants; 445 (88%) of 503 infants in NRT group and 443 (87%) of 507 infants in placebo.

39 inhibitory postsynaptic currents (IPSCs) in NRT and somatosensory relay cells to 11 and 12% of contr

40 TC neurons, but it was still not observed in NRT neurons.

41 nclude that activation of GABAB receptors in NRT leads to presynaptic autoinhibition of IPSCs in both

42 Of individuals contacted at 6 months, more NRT recipients than comparison group members successfull

43 Compared with the NRT-PCR, non-NRT-PCR was found to be less sensitive: it typed C. trac

44 rior pole of the reticular thalamic nucleus (NRT) were studied after injections of biotinylated dextr

45 known on the organization of connections of NRT with sensory thalamic nuclei in other species in tha

46 pact of informing smokers their oral dose of NRT is tailored to analysis of DNA.

47 Informing smokers their oral dose of NRT was tailored to genotype not phenotype had a small,

48 m to infants, we aimed to compare effects of NRT and placebo on infant development 2 years after deli

49 Subsequent effects of NRT on the children of treated mothers are unknown becau

50 oked IPSC was detected in only a minority of NRT cells (3 of 18).

51 After testing key falsifiable predictions of NRT using MEG recordings, we demonstrate the emergence o

52 At worst, the risks of NRT are no more than those of cigarette smoking.

53 The risks of NRT for smokers, even for those with underlying cardiova

54 Clinical trials of NRT in patients with underlying, stable coronary disease

55 Thus, use of NRT for less than 4 weeks was associated with reduced li

56 Use of NRT increased short-term cessation success in moderate t

57 ikelihood of cessation (for 4.0-7.9 weeks of NRT use, adjusted OR = 2.26, 95% CI: 1.58, 3.22; for 8.0

58 95% CI: 2.24, 6.58; and for >/= 12 weeks of NRT use, adjusted OR = 2.80, 95% CI: 1.70, 4.61).

59 6, 95% CI: 1.58, 3.22; for 8.0-11.9 weeks of NRT use, adjusted OR = 3.84, 95% CI: 2.24, 6.58; and for

60 nd e-cigarette-only use, but not dual use of NRTs or e-cigarettes with combustible cigarettes, is ass

61 of FIV with IAT compared with either IVT or NRT.

62 FIV (46 cm3 with IAT vs 149 cm3 with IVT or NRT; P < .001) compared with patients with an NIHSS scor

63 to 13 (22 cm3 with IAT vs 44 cm3 with IVT or NRT; P = .40).

64 r smokers with long-term e-cigarette-only or NRT-only use may obtain roughly similar levels of nicoti

65 long-term (>/=6 months) e-cigarette-only or NRT-only use, and long-term dual combustible cigarette-e

66 pants were informed that their doses of oral NRT were based either on their mu-opioid receptor (OPRM1

67 may occur sporadically in some users of oral NRT.

68 eloped and validated a nested real-time PCR (NRT-PCR) for the genotyping of Chlamydia trachomatis and

69 fferent between groups: (68.5% of prescribed NRT consumed in genotype vs 63.6%, phenotype group, diff

70 The proportion of prescribed NRT consumed in the first 28 days following quitting was

71 smoked ten cigarettes or more daily received NRT; most (64%) recipients were non-white, foreign-born,

72 As a result, NRT used in standard doses during pregnancy is considere

73 th esophageal cancer who did not undergo RT (NRT group).

74 ssed smoking status of 1305 randomly sampled NRT recipients and a non-randomly selected comparison gr

75 ix months, there was no evidence that saying NRT was tailored to genotype adversely affected motivati

76 Long-term NRT-only and e-cigarette-only use, but not dual use of N

77 neurons of the nucleus reticularis thalami (NRT) and thalamocortical (TC) neurons discharge high-fre

78 neurones of rat nucleus reticularis thalami (NRT) in vitro to assess pre- and postsynaptic GABAB rece

79 rtical (TC) and nucleus reticularis thalami (NRT) neurones, and possibly in neocortical cells, an I(T

80 neurons of the nucleus reticularis thalami (NRT).

81 The NRT-PCR had a 95% probability of detection at four genom

82 The NRT-selective genes were nominated by clustered SNPs tha

83 The results from the NRT-PCR and the DNA sequencing of amplicons generated fr

84 l ischemia versus only 1 patient (4%) in the NRT group (P = 0.001).

85 7% in the RT group and 59.3% +/- 9.8% in the NRT group (P = not significant).

86 At 2 years, 15 (3%) of 521 mothers in the NRT group and nine (2%) of 529 mothers in the placebo gr

87 ients in the RT group and 21 patients in the NRT group had normal GMPI results.

88 In the NRT group, 323 (73%) of 445 infants had no impairment co

89 the RT group and in 4 patients (16%) in the NRT group.

90 e included, 26 in the RT group and 25 in the NRT group.

91 The 11 probes used in the NRT-PCR correctly identified the DNA from D to K and LGV

92 for the IVT group (109 cm3; P = .001) or the NRT group (110 cm3; P < .01).

93 epresent an opportunity to further study the NRT mechanism in yeast.

94 le bond with a 65% ionic contribution to the NRT Mn-Sn bond order of 2.25.

95 Compared with the NRT-PCR, non-NRT-PCR was found to be less sensitive: it

96 were verified by a natural resonance theory (NRT) analysis of the electron density of the DFT-minimiz

97 alysis by means of Natural Resonance Theory (NRT) and Natural Bond Orbitals (NBOs) to investigate the

98 rix deletions, and natural resonance theory (NRT) descriptors, showing the general connection between

99 Neural resonance theory (NRT) provides a theoretical model explaining how an inte

100 inical trials, nicotine replacement therapy (NRT) and the antidepressant bupropion have been shown to

101 with regard to nicotine-replacement therapy (NRT) are presented.

102 tobacco use or nicotine replacement therapy (NRT) are sufficient to inhibit motoneuron apoptosis and

103 trial compared nicotine replacement therapy (NRT) patches with placebo in pregnant smokers; although

104 d used various nicotine replacement therapy (NRT) products.

105 en duration of nicotine replacement therapy (NRT) use and smoking cessation using data from the Ontar

106 with long-term nicotine replacement therapy (NRT) use only, long-term dual users of both combustible

107 ther combining nicotine replacement therapy (NRT) with varenicline to improve abstinence is effective

108 mokers who use nicotine replacement therapy (NRT), bupropion, or varenicline when trying to quit doub

109 bution of free nicotine replacement therapy (NRT).

110 ar risk during nicotine replacement therapy (NRT).

111 on treatments (nicotine replacement therapy [NRT], bupropion, and varenicline), which is most effecti

112 on-significant effect on 28-day adherence to NRT.

113 t 6038 successful quits were attributable to NRT receipt, and cost was 464 US dollars per quit.

114 e analogous to nonreciprocal translocations (NRTs) described in mammalian tumor cells and, thus, our

115 ns and complex nonreciprocal translocations (NRTs), whereas mTerc-transduced cultures maintained inta

116 scription of nicotine replacement treatment (NRT; reference group), bupropion, or varenicline.

117 The most effective way to use NRT is to combine the long-acting nicotine patch with a

118 A total of 17.2% of quitters used NRT, an antidepressant, or both as an aid to cessation i

119 Infants born to women who used NRT for smoking cessation in pregnancy were more likely

120 Using NRT was not associated with quitting when use duration w

121 = 0.51, 95% CI: 0.38, 0.67); however, using NRT for 4 weeks or longer was associated with a higher l

122 m NRT when attempting to quit smoking, using NRT for less than 4 weeks was associated with a lower li

123 ces on therapeutic responses to bupropion vs NRT.

124 ith reduced likelihood of cessation, whereas NRT use for longer periods of time was associated with a

125 To assess whether NRT use in pregnancy might cause harm to infants, we aim

126 es of smoking cessation were associated with NRT (17.6%) and bupropion (19.1%) compared with placebo

127 In combination with NRT patch, participants were informed that their doses o

128 Varenicline in combination with NRT was more effective than varenicline alone at achievi

129 ular or neuropsychiatric event compared with NRT (all hazard ratios [HRs] less than 1.

130 depression, or self-harm when compared with NRT.

131 cts of cigarette smoking in conjunction with NRT are similar to those of cigarette smoking alone.

132 1:1) to receive up to 8-weeks treatment with NRT (15 mg/16 h transdermal patches) or identically pack

133 t terminals on local axon collaterals within NRT as well as on projection fibres in the somatosensory

134 suggest that reciprocal connectivity within NRT can be partially mediated by a small GABAB inhibitor